Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.

A simple method for determining pyrimidine 5'-nucleotidase (P5N) activity in whole blood has been developed, inhibiting the plasma activity for UMP-hydrolysis by concanavalin (Con A). Con A specifically inhibits the activity of plasma 5'-nucleotidase (5N) but does not affect erythrocyte P5N activity...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Br J Ind Med
Egile Nagusiak:	Sakai, T, Araki, T, Ushio, K
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 1988
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1009621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2840110/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/oem.45.6.420
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!